Why Two Imaging Centers Changed Their Contrast Medium
With so many different gadolinium-based contrast agents (GBCAs) here is a manuscript of real-world
case histories of healthcare systems who have successfully made the switch from their existing GBCA
formulary to the first clinically available ionic, macrocyclic GBCA, DOTAREM® (gadoterate meglumine)
Disclaimer: The white paper sponsor may contact you but will not share the information you submit in the form.